Oppenheimer Upgrades Inspire Medical to Outperform with $85 Target After Q2 Beat

Company raises 2026 guidance and launches cost-cutting plan.

Oppenheimer Upgrades Inspire Medical to Outperform with $85 Target After Q2 Beat
Credit: Inspire Medical Systems
Already have an account? Sign in.